Related Experiment Video
Updated: Oct 3, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Do Opioid Addicts Require Higher Doses of Heparin During Percutaneous Coronary Intervention?
Tahereh Afaghnia1, Mohammad Nasim-Tajik2, Elham Boushehri3
1Student Research Committee, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Insights
Opioid addicts showed lower activated clotting time (ACT) during percutaneous coronary intervention (PCI) despite receiving standard heparin doses. This suggests opioid users may need increased heparin for effective anticoagulation during PCI.
Area of Science:
- Cardiology
- Pharmacology
- Addiction Medicine
Background:
- Percutaneous coronary intervention (PCI) necessitates anticoagulation, typically with heparin, to prevent thrombotic events.
- Opioid addiction may alter heparin's efficacy, potentially requiring dose adjustments during PCI procedures.
Purpose of the Study:
- To compare the effect of a standard heparin dose on activated clotting time (ACT) in opioid addicts versus non-addicts undergoing PCI.
- To investigate potential differences in anticoagulation response between these patient groups.
Main Methods:
- A comparative study involving 107 patients (50 opioid addicts, 57 non-addicts) scheduled for elective PCI.
- Standard heparin administration (100 IU/kg) at procedure start, with ACT measurements at 2 and 30 minutes.
- Baseline characteristics and coagulation parameters (PT, PTT, INR, platelet count) were recorded.
Main Results:
- Opioid addicts exhibited significantly lower ACT levels at both 2 and 30 minutes post-heparin administration compared to non-addicts.
- While hyperlipidemia was more prevalent in non-addicts and smoking in opioid addicts, baseline coagulation tests and heparin dosage were similar.
- ACT at 2 minutes correlated with aspirin use in opioid addicts and inversely with smoking in non-addicts.
Conclusions:
- Opioid addicts demonstrate a diminished response to standard heparin dosing during PCI, indicated by lower ACT.
- These findings suggest that opioid-addicted patients may require higher heparin doses to achieve adequate anticoagulation and prevent thrombotic complications during PCI.
Background:
Patients who undergo percutaneous coronary intervention (PCI) receive anticoagulants, most commonly heparin to prevent thrombotic events during the procedure. Opioid addicts may require higher doses of heparin for PCI. We aimed to compare the effect of heparin on activated clotting time (ACT) between opioid addicts and non-addicts prior to and during PCI.
Methods:
This comparative study included 107 patients scheduled for elective PCI, of whom 50 were opioid addicts and 57 non-addicts. Patients' baseline characteristics including age, gender, weight, comorbidities, drug history, and smoking were recorded. Prothrombin time (PT), ýpartial thromboplastin time (PTT), international normalized ratio (INR), and platelet count were measured in venous blood samples collected from all participants. All patients underwent PCI through femoral access. They received 100 IU/kg heparin right at the beginning of the procedure. ACT was measured at 2 and 30 minutes.
Findings:
Age, gender, weight, and the amount of heparin used were comparable between groups. As for general characteristics, the number of patients with hyperlipidemia was significantly higher in non-addicts (P = 0.031), and cigarette smoking was higher in opioid addicts (P < 0.001). No significant difference was found between the groups regarding PT, PTT, INR, and platelet count (P > 0.050). ACT at 2 and 30 min were significantly lower in opioid addicts (P < 0.001). Taking other variables into account, ACT at 2 min was directly correlated with drug history of aspirin in opioid addicts (P = 0.031) and inversely correlated with cigarette smoking in non-addicts (P = 0.023).
Conclusion:
Opioid addicts may require higher doses of heparin in PCI for the prevention of thrombotic complications compared to non-addicts.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care

